Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

This study aims at developing an accurate, simple, and cost-effective method for screening and early detection of uterine cancers

Condition or disease

Intervention/treatment

Uterine CancerEndometrial Cancer

Other: P2x7 assay

Detailed Description:

The present study aims at developing an accurate, simple and cost-effective method for screening and early detection of uterine cancers in women using novel inventions and biotechnology methods for collection and assay of uterine cells. Results of P2X7 assays using tissues obtained from women with known uterine cancer and from women with histologically normal endometrium will be compared. These data will also serve as basis for future studies to test the predictive value of the method in population-based studies.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

18 Years and older (Adult, Senior)

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

women scheduled to undergo hysterectomy

ages 18 years and older

Exclusion Criteria:

pregnant women

students or employees under the direct supervision on the investigators.